Ticker Scorecard - EVFM Basics Company: Evofem Biosciences, Inc. IPO Date: November 20, 2014 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.97% Avg Daily Range (30 D): $0.00 | 0.00% Avg Daily Range (90 D): $0.00 | 0.00% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 38 Avg Trade Size (Sh.) (30 D): 15,489 Avg Trade Size (Sh.) (90 D): 13,262 Institutional Trades Total Inst.Trades: 68 Avg Inst. Trade: $2.21M Avg Inst. Trade (30 D): $.5M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 1.01K     News Feb 13, 2025 @ 2:16 PM Evofem Strengthens SOLOSEC Intellectual Property w... Source: Prnewswire Aug 11, 2022 @ 9:28 AM Why Invitae Climbed Around 279%; Here Are 98 Bigge... Source: Lisa Levin Aug 10, 2022 @ 7:52 AM Why Avalo Therapeutics Surged 32%; Here Are 111 Bi... Source: Lisa Levin Aug 9, 2022 @ 5:26 PM Why Verona Pharma Is Trading Higher By Around 84%,... Source: Lisa Levin Aug 8, 2022 @ 7:05 AM Why Quoin Pharmaceuticals Plunged Over 62%; Here A... Source: Lisa Levin Financials   TTM Q4 2022 Q2 2022 Basic EPS $-11.15 $.31 $-4.57 Diluted EPS $-.13 $.31 $-4.57 Revenue $ 17.1M $ .18M $ 6.03M Gross Profit $ 13.82M $ -.2M $ 4.75M Net Income / Loss $ -7.94M $ -8.34M $ -125.98M Operating Income / Loss $ -10.05M $ -12.05M $ -24.42M Cost of Revenue $ 3.28M $ .38M $ 1.29M Net Cash Flow $ .31M $ -5.07M $ 14.53M PE Ratio     Splits May 18, 2023:   125:1 May 06, 2022:   15:1 Jan 18, 2018:   6:1